SCHEMBL5474154

SCHEMBL5474154

O=S(=O)(Nc1ccc2ccccc2n1)N1CCCCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
ALDH1A1 P00352 2/20 0.58
HTT P42858 2/20 0.58
MAPK1 P28482 1/20 0.58
KDM4E B2RXH2 3/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
CNR2 P34972 1/20 0.50
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
KDM4C Q9H3R0 1/20 0.49
PKM P14618 1/20 0.49
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
NCF1 P14598 1/20 0.45
MAPT P10636 3/20 0.45
FKBP1A P62942 3/20 0.44
GLA P06280 1/20 0.44
MCOLN3 Q8TDD5 2/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5471685 1.00 LMNA (0.58) LMNAALDH1A1HTTMAPK1KDM4E
SCHEMBL5468428 0.83 NPC1 (0.51) LMNAALDH1A1HTTMAPK1KDM4E
SCHEMBL5468258 0.83 USP30 (0.43) LMNAALDH1A1HTTMAPK1KDM4E
SCHEMBL5474755 0.81 NPC1 (0.56) LMNAALDH1A1HTTMAPK1KDM4E
SCHEMBL5487139 0.80 ALDH1A1 (0.40) LMNAALDH1A1HTTMAPK1KDM4E
SCHEMBL5471742 0.79 KDM4E (0.52) LMNAALDH1A1MAPK1KDM4EHSD17B10
SCHEMBL5473669 0.79 PDE10A (0.40) LMNAALDH1A1HTTMAPK1KDM4E
SCHEMBL5466694 0.78 HTR3E (0.46) ALDH1A1HTTMAPK1KDM4EHPGD
SCHEMBL5471161 0.77 KDM4E (0.47) LMNAALDH1A1HTTMAPK1KDM4E
SCHEMBL5474938 0.77 GAA (0.50) LMNAALDH1A1HTTMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives HSD11B1, HSD11B2, HSD17B11 LMNA 4239/4885ALDH1A1 74/4885HTT 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.